These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 21398613

  • 1. Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease.
    Mao C, Wang S, Xiao Y, Xu J, Jiang Q, Jin M, Jiang X, Guo H, Ning G, Zhang Y.
    J Immunol; 2011 Apr 15; 186(8):4734-43. PubMed ID: 21398613
    [Abstract] [Full Text] [Related]

  • 2. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S.
    Arthritis Rheum; 2008 Mar 15; 58(3):801-12. PubMed ID: 18311820
    [Abstract] [Full Text] [Related]

  • 3. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
    McLachlan SM, Nagayama Y, Pichurin PN, Mizutori Y, Chen CR, Misharin A, Aliesky HA, Rapoport B.
    Endocrinology; 2007 Dec 15; 148(12):5724-33. PubMed ID: 17823263
    [Abstract] [Full Text] [Related]

  • 4. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F, St-Pierre J, Piccirillo CA, Stevenson MM.
    J Immunol; 2011 Apr 15; 186(8):4862-71. PubMed ID: 21389253
    [Abstract] [Full Text] [Related]

  • 5. Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.
    Bossowski A, Moniuszko M, Dąbrowska M, Sawicka B, Rusak M, Jeznach M, Wójtowicz J, Bodzenta-Lukaszyk A, Bossowska A.
    Autoimmunity; 2013 May 15; 46(3):222-30. PubMed ID: 23249428
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS, Krishnadas DK, Agrawal B.
    Int Immunol; 2007 Mar 15; 19(3):227-37. PubMed ID: 17289657
    [Abstract] [Full Text] [Related]

  • 7. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L, Yang P, Zhou H, He H, Ren X, Chi W, Wang L, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2008 Aug 15; 49(8):3475-82. PubMed ID: 18421089
    [Abstract] [Full Text] [Related]

  • 8. Regulatory T cells in Graves' disease.
    Pan D, Shin YH, Gopalakrishnan G, Hennessey J, De Groot LJ.
    Clin Endocrinol (Oxf); 2009 Oct 15; 71(4):587-93. PubMed ID: 19222488
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, Zhao GJ, Dong N, Sheng ZY.
    J Pharmacol Exp Ther; 2010 Dec 15; 335(3):553-61. PubMed ID: 20843956
    [Abstract] [Full Text] [Related]

  • 10. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals.
    Maggi L, Santarlasci V, Liotta F, Frosali F, Angeli R, Cosmi L, Maggi E, Romagnani S, Annunziato F.
    J Allergy Clin Immunol; 2007 Aug 15; 120(2):429-36. PubMed ID: 17604089
    [Abstract] [Full Text] [Related]

  • 11. CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model.
    Saitoh O, Abiru N, Nakahara M, Nagayama Y.
    Endocrinology; 2007 Dec 15; 148(12):6040-6. PubMed ID: 17823258
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.
    Xu G, Mou Z, Jiang H, Cheng L, Shi J, Xu R, Oh Y, Li H.
    Laryngoscope; 2007 May 15; 117(5):876-80. PubMed ID: 17473687
    [Abstract] [Full Text] [Related]

  • 15. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y.
    Transpl Immunol; 2007 Apr 15; 17(3):153-61. PubMed ID: 17331841
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.
    Berntsen A, Brimnes MK, thor Straten P, Svane IM.
    J Immunother; 2010 May 15; 33(4):425-34. PubMed ID: 20386464
    [Abstract] [Full Text] [Related]

  • 19. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
    Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC, Kallenberg CG.
    Arthritis Rheum; 2007 Jun 15; 56(6):2080-91. PubMed ID: 17530650
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.